Proprietary Organ Preservation Technology: Transmedics' OCS (Organ Care System) is a unique, patented platform that actively perfuses donor organs, extending preservation time and allowing for viability assessment, a significant advancement over traditional static cold storage.

Significant Regulatory Barriers to Entry: The company has secured crucial FDA Pre-Market Approvals (PMAs) for OCS Heart, Lung, and Liver, representing years of extensive clinical trials and regulatory hurdles that new competitors would face.

Demonstrated Clinical Superiority: Clinical studies have shown OCS can expand the donor pool, reduce organ discard rates, and improve post-transplant outcomes compared to conventional cold storage methods.